Edible-THC Temperature Tolerance Did Not Prevent a Motor Finding in Adolescent Mice

Adolescent mice showed evidence of tolerance to THC-related hypothermia while also showing poorer motor coordination during short-term abstinence. Adaptation on one physiological measure did not establish normal performance on another.

Voluntary consumption rather than injected THC

The study gave male adolescent mice limited access to THC-containing or control dough and ethanol or water. Home-cage movement was recorded, and later tests examined motor performance, temperature responses, blood ethanol and brain CB1 receptor expression.

Consumption and outcomes diverged

Edible THC suppressed movement, whereas alcohol increased activity under the tested conditions. Prior edible THC consumption was associated with a reduced hypothermic response to a THC challenge. It also impaired subsequent drug-free rotarod performance, a motor-coordination endpoint.

The alcohol comparison remained negative

The alcohol-access regimen did not produce significant functional or metabolic tolerance on the later alcohol challenge. Those null findings matter: the co-use model did not demonstrate the same adaptation to each substance. Neither alcohol intake nor consumed THC dose showed a significant association with the measured CB1 expression.

Limits of an adolescent co-use model

Only male mice were studied, intake varied and the laboratory access schedule was specific. Rotarod behavior and temperature cannot define a human waiting period after an edible, and a mouse day is not a validated human recovery interval. The paper supports separating route, prior intake, physiological tolerance and functional performance rather than treating any one as a clearance certificate.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Smoker MP; Hernandez M; Zhang Y; Boehm SL. Assessment of Acute Motor Effects and Tolerance Following Self-Administration of Alcohol and Edible ∆9 -Tetrahydrocannabinol in Adolescent Male Mice. Alcoholism, clinical and experimental research (2019). DOI: 10.1111/acer.14197.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A CB1 Mutation Changed Cannabinoid Tolerance Differently Across Testing Methods

A receptor mutation delayed tolerance to WIN55,212-2 more consistently than to CP55,940, and the result also depended on how tolerance was measured. Fixed-dose behavior and dose-response shifts were different tests. Two agonists and several endpoints Investigators compared desensitization-resistant S426A/S430A mice with controls in thermal, formalin and chemotherapy-neuropathy experiments. Both challenge…

Spread the love

Read Article: A CB1 Mutation Changed Cannabinoid Tolerance Differently Across Testing Methods

Endocannabinoid Enzyme Inhibition Delayed Neuropathy Without Permanently Preventing It

Two FAAH inhibitors suppressed pain-related behavior during treatment, but neuropathy emerged after restricted preventive dosing stopped. Delaying an endpoint was not the same as permanently preventing the condition. Indirect cannabinoid-system modulation Researchers compared brain-permeant URB597, peripherally restricted URB937 and a direct synthetic agonist in paclitaxel-treated mice. FAAH inhibition alters endogenous…

Spread the love

Read Article: Endocannabinoid Enzyme Inhibition Delayed Neuropathy Without Permanently Preventing It

A GPR55 Barrier Study Did Not Demonstrate THC-Induced Blood–Brain Barrier Injury

A study of GPR55 activation changed experimental barrier measurements, but its test substance was lysophosphatidylinositol, not THC. A cannabinoid-related receptor label cannot substitute for the actual exposure. Cells and animals answered different questions Researchers examined rat brain microvascular endothelial cells using calcium, electrical-resistance and junction-related measurements. Animal experiments also assessed…

Spread the love

Read Article: A GPR55 Barrier Study Did Not Demonstrate THC-Induced Blood–Brain Barrier Injury

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us